These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12789283)

  • 1. Gene-expression profiling in human cutaneous melanoma.
    Carr KM; Bittner M; Trent JM
    Oncogene; 2003 May; 22(20):3076-80. PubMed ID: 12789283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
    Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
    Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.
    Jansen B; Schlagbauer-Wadl H; Brown BD; Bryan RN; van Elsas A; Müller M; Wolff K; Eichler HG; Pehamberger H
    Nat Med; 1998 Feb; 4(2):232-4. PubMed ID: 9461199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma: fishing with chips.
    Nambiar S; Mirmohammadsadegh A; Hengge UR
    Curr Mol Med; 2008 May; 8(3):235-43. PubMed ID: 18473822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
    Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
    J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
    Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
    Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside.
    Hocker TL; Singh MK; Tsao H
    J Invest Dermatol; 2008 Nov; 128(11):2575-2595. PubMed ID: 18927540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
    Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
    Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells.
    Mukherjee N; Schwan JV; Fujita M; Norris DA; Shellman YG
    J Invest Dermatol; 2015 Sep; 135(9):2155-2161. PubMed ID: 25947358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.
    Parker CJ; Shawcross SG; Li H; Wang QY; Herrington CS; Kumar S; MacKie RM; Prime W; Rennie IG; Sisley K; Kumar P
    Int J Cancer; 2004 Jan; 108(2):314-20. PubMed ID: 14639621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages.
    Olie RA; Hafner C; Küttel R; Sigrist B; Willers J; Dummer R; Hall J; Stahel RA; Zangemeister-Wittke U
    J Invest Dermatol; 2002 Mar; 118(3):505-12. PubMed ID: 11874491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.